Clinical trial
Lamictal in the Treatment of Post-Herpetic Neuralgia
NCT00295776 · George Washington University, Other · Terminated
Key facts
| NCT number | NCT00295776 |
|---|---|
| Title | Lamictal in the Treatment of Post-Herpetic Neuralgia |
| Official title | Lamictal in the Treatment of Post-Herpetic Neuralgia-A Safety, Efficacy,Randomized, Double Blind, Placebo Controlled, Cross-Over Study |
| Lead sponsor | George Washington University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Neuralgia, Postherpetic |
| Intervention type | Drug |
| Interventions | Lamictal in the treatment of Post-Herpetic Neuralgia |
| Start date | Feb 1, 2005 |
| Primary completion | Dec 1, 2007 |
| First posted | Feb 24, 2006 |
| Last update posted | Mar 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: